Cargando…

N6AMT1 is a novel potential diagnostic, prognostic and immunotherapy response biomarker in pan-cancer

Background: The N-6-adenine-specific DNA methyltransferase 1 (N6AMT1) is the only writer responsible for DNA 6mA modifications. At present, its role in cancer is still unclear, and further systematic pan-cancer analysis is needed to explore its value in diagnosis, prognosis and immunological functio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Mingqi, Zhu, Jiajie, Ye, Yingquan, Li, Ping, Sun, Weijie, Zhang, Mei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2023
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373955/ https://www.ncbi.nlm.nih.gov/pubmed/37437243 http://dx.doi.org/10.18632/aging.204868

Ejemplares similares

Role of ARRB1 in prognosis and immunotherapy: A Pan-Cancer analysis
por: Ye, Yingquan, et al.
Publicado: (2022)

Preparation and Characterization of AMT/Co(acac)(3)-Loaded PAN/PS Micro-Nanofibers with Large through-Pores
por: Wang, Fei-Fei, et al.
Publicado: (2019)

HIF1α: A Novel Biomarker with Potential Prognostic and Immunotherapy in Pan-cancer
por: Tian, Yonggang, et al.
Publicado: (2022)

Pan-Cancer Analysis of the Prognostic and Immunological Role of HSF1: A Potential Target for Survival and Immunotherapy
por: Chen, Fei, et al.
Publicado: (2021)

Pan-Cancer Analysis of the N6-Methyladenosine Eraser FTO as a Potential Prognostic and Immunological Biomarker
por: Zhao, Chengwen, et al.
Publicado: (2021)

Structural insight into human N6amt1–Trm112 complex functioning as a protein methyltransferase
por: Li, Wenjing, et al.
Publicado: (2019)

GPC2 Is a Potential Diagnostic, Immunological, and Prognostic Biomarker in Pan-Cancer
por: Chen, Guoming, et al.
Publicado: (2022)

MCM10, a potential diagnostic, immunological, and prognostic biomarker in pan-cancer
por: Chen, Dengwang, et al.
Publicado: (2023)

N-6-Adenine-Specific DNA Methyltransferase 1 (N6AMT1) Polymorphisms and Arsenic Methylation in Andean Women
por: Harari, Florencia, et al.
Publicado: (2013)

Glycolysis-Related SLC2A1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy
por: Zheng, Haosheng, et al.
Publicado: (2022)

PHF5A is a potential diagnostic, prognostic, and immunological biomarker in pan-cancer
por: Ding, Na, et al.
Publicado: (2023)

Pan-Cancer Analysis of IGF-1 and IGF-1R as Potential Prognostic Biomarkers and Immunotherapy Targets
por: Zhang, Yinqi, et al.
Publicado: (2021)

Association of N6AMT1 rs2254638 Polymorphism With Clopidogrel Response in Chinese Patients With Coronary Artery Disease
por: Li, He, et al.
Publicado: (2018)

Evolution of Electrogenic Ammonium Transporters (AMTs)
por: McDonald, Tami R., et al.
Publicado: (2016)

Genome-Wide Identification of AMT2-Type Ammonium Transporters Reveal That CsAMT2.2 and CsAMT2.3 Potentially Regulate NH(4)(+) Absorption among Three Different Cultivars of Camellia sinensis
por: Zhang, Wenjing, et al.
Publicado: (2022)

Integrated pan-cancer analysis of CSMD2 as a potential prognostic, diagnostic, and immune biomarker
por: Zhang, Huiyun, et al.
Publicado: (2022)

Allograft inflammatory factor 1 is a potential diagnostic, immunological, and prognostic biomarker in pan-cancer
por: Liu, Xin, et al.
Publicado: (2023)

YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy
por: Hu, Jian, et al.
Publicado: (2021)

Ancient genes can be served as pan‐cancer diagnostic and prognostic biomarkers
por: Ji, Xiangwen, et al.
Publicado: (2020)

Involvement of N-6 Adenine-Specific DNA Methyltransferase 1 (N6AMT1) in Arsenic Biomethylation and Its Role in Arsenic-Induced Toxicity
por: Ren, Xuefeng, et al.
Publicado: (2011)

The Common Partner of Several Methyltransferases TRMT112 Regulates the Expression of N6AMT1 Isoforms in Mammalian Cells
por: Leetsi, Lilian, et al.
Publicado: (2019)

Analysis of the AMT gene family in chili pepper and the effects of arbuscular mycorrhizal colonization on the expression patterns of CaAMT2 genes
por: Fang, Lei, et al.
Publicado: (2023)

Zic Family Member 2 (ZIC2): a Potential Diagnostic and Prognostic Biomarker for Pan-Cancer
por: Lv, Zhengtong, et al.
Publicado: (2021)

HMMR potential as a diagnostic and prognostic biomarker of cancer—speculation based on a pan-cancer analysis
por: Shang, Junyi, et al.
Publicado: (2023)

RelB is a potential molecular biomarker for immunotherapy in human pan-cancer
por: Wu, Jintao, et al.
Publicado: (2023)

Functional Identification and Genetic Transformation of the Ammonium Transporter PtrAMT1;6 in Populus
por: Yang, Chengjun, et al.
Publicado: (2023)

Pan-cancer analysis and experimental validation of DTL as a potential diagnosis, prognosis and immunotherapy biomarker
por: Tang, Yumei, et al.
Publicado: (2023)

Reducing N6AMT1-mediated 6mA DNA modification promotes breast tumor progression via transcriptional repressing cell cycle inhibitors
por: Chen, Jiongyu, et al.
Publicado: (2022)

HHH-AMT Workshop on Superconducting Pulsed Magnets for Accelerators
por: Rossi, L
Publicado: (2006)

Sequence and expression analysis of the AMT gene family in poplar
por: Wu, Xiangyu, et al.
Publicado: (2015)

Characterization of AmtA, an amidinotransferase involved in the biosynthesis of phaseolotoxins
por: Li, Mi, et al.
Publicado: (2016)

Functional and Regulatory Characterization of Three AMTs in Maize Roots
por: Hao, Dong-Li, et al.
Publicado: (2020)

TaAMT2;3a, a wheat AMT2-type ammonium transporter, facilitates the infection of stripe rust fungus on wheat
por: Jiang, Junpeng, et al.
Publicado: (2019)

An integrated pan-cancer analysis of PSAT1: A potential biomarker for survival and immunotherapy
por: Feng, Mingtao, et al.
Publicado: (2022)

Pan-Cancer Analysis of FURIN as a Potential Prognostic and Immunological Biomarker
por: Zhou, Bolun, et al.
Publicado: (2021)

Identification of OTUD6B as a new biomarker for prognosis and immunotherapy by pan-cancer analysis
por: Zhao, Guang, et al.
Publicado: (2022)

Pan-cancer analyses confirmed the cuproptosis-related gene FDX1 as an immunotherapy predictor and prognostic biomarker
por: Zhang, Chi, et al.
Publicado: (2022)

KNSTRN, a Poor Prognostic Biomarker, Affects the Tumor Immune Microenvironment and Immunotherapy Outcomes in Pan-Cancer
por: Zhang, Wanli, et al.
Publicado: (2023)

A Systematic Pan-Cancer Analysis of MEIS1 in Human Tumors as Prognostic Biomarker and Immunotherapy Target
por: Li, Han, et al.
Publicado: (2023)

IgG N-glycan Signatures as Potential Diagnostic and Prognostic Biomarkers
por: Haslund-Gourley, Benjamin S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hpie3vbdj8i8b6o6e2o14aks84